查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1601055

間質幹細胞市場：按類型、適應症、分離來源、應用分類 - 2025-2030 年全球預測

Mesenchymal Stem Cells Market by Type (Allogeneic, Autologous), Indication (Bone & Cartilage Repair, Cancer, Cardiovascular Disease), Source of Isolation, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

間質幹細胞市場2023年估值為35.1億美元，預計到2024年將達到39.8億美元，複合年成長率為13.63%，預計到2030年將達到85.9億美元。

間質幹細胞（MSC）是多功能基質細胞，可分化成各種細胞類型，包括骨頭、軟骨和脂肪。間質幹細胞在再生醫學的應用範圍非常廣泛，其在組織工程、自體免疫疾病治療及其在調節免疫反應中的作用的潛在應用就是例證。主要應用包括心血管、整形外科和神經系統疾病的再生治療。製藥、生物技術和醫療保健等行業是 MSC 技術的主要最終應用領域。面對慢性疾病的增加和人口老化，對創新治療方法的需求不斷成長，這凸顯了對間質幹細胞的需求，刺激了基於間質幹細胞的新型產品的研究和投資。市場成長主要受到幹細胞治療技術進步、研究經費增加以及支持再生醫學的有利政府法規的推動。學術界和生技公司之間不斷加強的研究合作進一步凸顯了突破性治療方法的潛力。然而，諸如嚴格的監管核准、基於間質幹細胞的治療方法的高成本、倫理問題以及幹細胞分化和擴增的技術困難等挑戰可能會阻礙市場的進步。此外，可變的臨床結果和可擴展性問題也帶來了額外的障礙。創新的關鍵領域包括增強幹細胞功效和輸送機制、開發可擴展的製造流程以及建構即時生理監測平台。隨著 MSC 市場的發展，研發方面的策略性投資、強調遵守法規結構以及建立技術共用夥伴關係對於持續成長至關重要。總體而言，間質幹細胞代表了再生醫學領域一個充滿希望但充滿挑戰的前沿領域，對於那些能夠駕馭複雜的臨床、監管和市場格局的人來說具有巨大的潛力。

主要市場統計
基準年[2023] 35.1億美元
預測年份 [2024] 39.8億美元
預測年份 [2030] 85.9億美元
複合年成長率（%） 13.63%

市場動態：快速發展的間質幹細胞市場的關鍵市場洞察

供需的動態交互作用正在改變間間質幹細胞市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 基於間質幹細胞的研究的發展
    • 老年人口增加和慢性病增加
    • 幹細胞治療不斷發展的前景
  • 市場限制因素
    • 幹細胞治療缺乏標準化和監管
  • 市場機會
    • 間質幹細胞的新應用
    • 擴大間間質幹細胞產品的合作研究和夥伴關係並推動治療創新
  • 市場挑戰
    • 與間質幹細胞治療相關的倫理和安全問題

波特的五力：駕馭間質幹細胞市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解間質幹細胞市場的外部影響

外部宏觀環境因素在塑造間質幹細胞市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解間質幹細胞市場的競爭狀況

對間質幹細胞市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位間質幹細胞市場供應商績效評估

FPNV定位矩陣是評估間質幹細胞市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。四個象限清楚且準確地分類供應商，幫助使用者辨識最能滿足其策略目標的合作夥伴和解決方案。

本報告提供了涵蓋關鍵重點領域的全面市場分析：

1. 市場滲透率：對當前市場環境的詳細回顧，包括行業主要企業的大量資料。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 間質幹細胞的生長研究
      • 老年人口增加和慢性病增加
      • 幹細胞治療的持續前景
    • 抑制因素
      • 幹細胞治療缺乏標準化和監管
    • 機會
      • 間質幹細胞的新應用
      • 擴大間間質幹細胞產品合作和夥伴關係並推動治療創新
    • 任務
      • 與人類 MSC 治療相關的倫理和安全問題
  • 市場區隔分析
    • 類型：自體間質幹細胞的免疫安全性和個人化使其有利於長期治療
    • 適應症：用於 CVD 治療的 MSC 的大量研發活動
    • 分離來源：骨髓間質幹細胞的高細胞產量和已建立的治療用途
    • 應用：間質幹細胞由於能夠模擬人類疾病和測試藥物療效，在疾病建模和藥物發現方面具有優勢
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境
  • 客戶客製化

間質幹細胞市場：依類型

  • 同種異體的
  • 自體移植

間質幹細胞市場的適應症

  • 骨頭和軟骨修復
  • 癌症
  • 心血管疾病
  • 移植物抗宿主疾病
  • 發炎和免疫疾病
  • 肝臟疾病

間質幹細胞市場依來源隔離

  • 脂肪組織
  • 骨髓
  • 臍帶血
  • 輸卵管
  • 胎兒肝臟
  • 肺
  • 周邊血

間質幹細胞市場：依應用分類

  • 疾病模型
  • 藥物開發和發現
  • 幹細胞銀行
  • 組織工程
  • 毒理學研究

第10章 北美及南美間間質幹細胞市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區間間質幹細胞市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲間間質幹細胞市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Cellcolabs 宣布與 REPROCELL 合作
    • PromoCell 推出 PromoExQ MSC 生長培養基 XF，用於符合 GMP 的間質幹細胞分離與擴增
    • Pluristyx 和 Stemmatters 宣布合作開發和製造 iPSC 衍生的 MSC 銀行

公司名單

  • PromoCell GmbH
  • Globus Medical
  • Pluri Biotech Ltd.
  • ScienCell Research Laboratories, Inc.
  • Stemedica Cell Technologies, Inc.
  • Cyagen Biosciences, Inc.
  • BrainStorm Cell Therapeutics Inc.
  • Stemcell Technologies Inc.
  • AMS Biotechnology
  • Mesoblast Limited
  • Thermo Fisher Scientific, Inc.
  • Lonza Group AG
  • Merck KGaA
  • Genlantis, Inc.
  • Celprogen, Inc.
  • Takeda Pharmaceutical Company Limited
  • Athersys, Inc.
  • R&D Systems, Inc.
  • Smith & Nephew PLC
  • Cytori Therapeutics Inc.
  • Axol Biosciences Ltd.
  • Neuromics
  • Vericel Corporation
  • Hope Biosciences, LLC
  • Cell Applications, Inc.
  • Astellas Pharma Inc.
Product Code: MRR-B973EDD5ED66

The Mesenchymal Stem Cells Market was valued at USD 3.51 billion in 2023, expected to reach USD 3.98 billion in 2024, and is projected to grow at a CAGR of 13.63%, to USD 8.59 billion by 2030.

Mesenchymal Stem Cells (MSCs) are multipotent stromal cells capable of differentiating into various cell types, including bone, cartilage, and fat. The scope of MSCs in regenerative medicine is vast, epitomized by their potential use in tissue engineering, the treatment of autoimmune diseases, and their role in modulating immune responses. Key applications include regenerative treatments for cardiovascular, orthopedic, and neurological disorders. Industries such as pharmaceuticals, biotechnology, and healthcare are primary end-use sectors for MSC technologies. The necessity of MSCs is underscored by the growing demand for innovative therapies in the face of rising chronic diseases and an aging population, fueling research and investments in novel MSC-based products. Market growth is significantly influenced by technological advancements in stem cell therapy, increased funding for research, and favorable government regulations supporting regenerative medicine, thereby creating opportunities for new market entrants and existing players to expand their offerings. The rise in collaborations between academia and biotech firms further accentuates the potential for groundbreaking therapies. However, challenges such as stringent regulatory approvals, high costs of MSC-based therapies, ethical concerns, and technical difficulties in stem cell differentiation and proliferation can impede market progress. Moreover, the varied clinical outcomes and scalability issues pose additional hurdles. Key areas of innovation include enhancing MSC potency and delivery mechanisms, developing scalable manufacturing processes, and creating platforms for real-time physiological monitoring. As the MSC market evolves, strategic investments in R&D, emphasis on compliance with regulatory frameworks, and the establishment of partnerships for technology sharing will be critical for sustained growth. Overall, MSCs present a promising yet challenging frontier in regenerative medicine, with remarkable potential for those capable of navigating the complex clinical, regulatory, and market landscapes.

KEY MARKET STATISTICS
Base Year [2023] USD 3.51 billion
Estimated Year [2024] USD 3.98 billion
Forecast Year [2030] USD 8.59 billion
CAGR (%) 13.63%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Mesenchymal Stem Cells Market

The Mesenchymal Stem Cells Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growth in Mesenchymal Stem Cell-Based Research
    • Rising Geriatric Population Coupled with Growth in Chronic Diseases
    • Continuously Evolving Landscape of Stem Cell Therapies
  • Market Restraints
    • Lack of Standardized and Regulated Delivery of Stem Cell Therapy
  • Market Opportunities
    • Emerging Applications of Mesenchymal Stem Cells
    • Growing Collaborations and Partnerships and Advancing Therapeutic Innovations of Mesenchymal Stem Cell Products
  • Market Challenges
    • Ethical & Safety Issues Associated with Human MSC Therapy

Porter's Five Forces: A Strategic Tool for Navigating the Mesenchymal Stem Cells Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Mesenchymal Stem Cells Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Mesenchymal Stem Cells Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Mesenchymal Stem Cells Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Mesenchymal Stem Cells Market

A detailed market share analysis in the Mesenchymal Stem Cells Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Mesenchymal Stem Cells Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Mesenchymal Stem Cells Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Mesenchymal Stem Cells Market, highlighting leading vendors and their innovative profiles. These include PromoCell GmbH, Globus Medical, Pluri Biotech Ltd., ScienCell Research Laboratories, Inc., Stemedica Cell Technologies, Inc., Cyagen Biosciences, Inc., BrainStorm Cell Therapeutics Inc., Stemcell Technologies Inc., AMS Biotechnology, Mesoblast Limited, Thermo Fisher Scientific, Inc., Lonza Group AG, Merck KGaA, Genlantis, Inc., Celprogen, Inc., Takeda Pharmaceutical Company Limited, Athersys, Inc., R&D Systems, Inc., Smith & Nephew PLC, Cytori Therapeutics Inc., Axol Biosciences Ltd., Neuromics, Vericel Corporation, Hope Biosciences, LLC, Cell Applications, Inc., and Astellas Pharma Inc..

Market Segmentation & Coverage

This research report categorizes the Mesenchymal Stem Cells Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Allogeneic and Autologous.
  • Based on Indication, market is studied across Bone & Cartilage Repair, Cancer, Cardiovascular Disease, GvHD, Inflammatory & Immunological Disease, and Liver Diseases.
  • Based on Source of Isolation, market is studied across Adipose Tissues, Bone Marrow, Cord Blood, Fallopian Tube, Fetal Liver, Lung, and Peripheral Blood.
  • Based on Application, market is studied across Disease Modeling, Drug Development & Discovery, Stem Cell Banking, Tissue Engineering, and Toxicology Studies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growth in Mesenchymal Stem Cell-Based Research
      • 5.1.1.2. Rising Geriatric Population Coupled with Growth in Chronic Diseases
      • 5.1.1.3. Continuously Evolving Landscape of Stem Cell Therapies
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of Standardized and Regulated Delivery of Stem Cell Therapy
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging Applications of Mesenchymal Stem Cells
      • 5.1.3.2. Growing Collaborations and Partnerships and Advancing Therapeutic Innovations of Mesenchymal Stem Cell Products
    • 5.1.4. Challenges
      • 5.1.4.1. Ethical & Safety Issues Associated with Human MSC Therapy
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Immunological safety and personalized nature of autologous MSCs to make them beneficial for long-term treatments
    • 5.2.2. Indication: Substantial research and development activities on MSCs for the treatment of CVDs
    • 5.2.3. Source of Isolation: High cell yield and established therapeutic use of bone-marrow derived MSC
    • 5.2.4. Application: Benefits of MSCs in disease modeling and drug discovery due to their ability to mimic human diseases and test drug efficacy
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental
  • 5.5. Client Customization

6. Mesenchymal Stem Cells Market, by Type

  • 6.1. Introduction
  • 6.2. Allogeneic
  • 6.3. Autologous

7. Mesenchymal Stem Cells Market, by Indication

  • 7.1. Introduction
  • 7.2. Bone & Cartilage Repair
  • 7.3. Cancer
  • 7.4. Cardiovascular Disease
  • 7.5. GvHD
  • 7.6. Inflammatory & Immunological Disease
  • 7.7. Liver Diseases

8. Mesenchymal Stem Cells Market, by Source of Isolation

  • 8.1. Introduction
  • 8.2. Adipose Tissues
  • 8.3. Bone Marrow
  • 8.4. Cord Blood
  • 8.5. Fallopian Tube
  • 8.6. Fetal Liver
  • 8.7. Lung
  • 8.8. Peripheral Blood

9. Mesenchymal Stem Cells Market, by Application

  • 9.1. Introduction
  • 9.2. Disease Modeling
  • 9.3. Drug Development & Discovery
  • 9.4. Stem Cell Banking
  • 9.5. Tissue Engineering
  • 9.6. Toxicology Studies

10. Americas Mesenchymal Stem Cells Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Mesenchymal Stem Cells Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Mesenchymal Stem Cells Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Cellcolabs Announces Partnership With REPROCELL for Research And GMP Grade MSC And MSC Derivatives
    • 13.3.2. PromoCell Launches PromoExQ MSC Growth Medium XF for GMP-Compliant Isolation and Expansion of Mesenchymal Stem Cells
    • 13.3.3. Pluristyx and Stemmatters Announce Partnership to Develop and Manufacture iPSC-derived MSC Banks

Companies Mentioned

  • 1. PromoCell GmbH
  • 2. Globus Medical
  • 3. Pluri Biotech Ltd.
  • 4. ScienCell Research Laboratories, Inc.
  • 5. Stemedica Cell Technologies, Inc.
  • 6. Cyagen Biosciences, Inc.
  • 7. BrainStorm Cell Therapeutics Inc.
  • 8. Stemcell Technologies Inc.
  • 9. AMS Biotechnology
  • 10. Mesoblast Limited
  • 11. Thermo Fisher Scientific, Inc.
  • 12. Lonza Group AG
  • 13. Merck KGaA
  • 14. Genlantis, Inc.
  • 15. Celprogen, Inc.
  • 16. Takeda Pharmaceutical Company Limited
  • 17. Athersys, Inc.
  • 18. R&D Systems, Inc.
  • 19. Smith & Nephew PLC
  • 20. Cytori Therapeutics Inc.
  • 21. Axol Biosciences Ltd.
  • 22. Neuromics
  • 23. Vericel Corporation
  • 24. Hope Biosciences, LLC
  • 25. Cell Applications, Inc.
  • 26. Astellas Pharma Inc.

LIST OF FIGURES

  • FIGURE 1. MESENCHYMAL STEM CELLS MARKET RESEARCH PROCESS
  • FIGURE 2. MESENCHYMAL STEM CELLS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. MESENCHYMAL STEM CELLS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. MESENCHYMAL STEM CELLS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MESENCHYMAL STEM CELLS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MESENCHYMAL STEM CELLS MARKET DYNAMICS
  • TABLE 7. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY ALLOGENEIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY BONE & CARTILAGE REPAIR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY GVHD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY INFLAMMATORY & IMMUNOLOGICAL DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY LIVER DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY ADIPOSE TISSUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY BONE MARROW, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY CORD BLOOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY FALLOPIAN TUBE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY FETAL LIVER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY LUNG, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY PERIPHERAL BLOOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY DISEASE MODELING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY DRUG DEVELOPMENT & DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY STEM CELL BANKING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY TOXICOLOGY STUDIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. INDIA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. INDONESIA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. INDONESIA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 76. INDONESIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. JAPAN MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. JAPAN MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 80. JAPAN MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 81. JAPAN MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. MALAYSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. MALAYSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 84. MALAYSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 85. MALAYSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. PHILIPPINES MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. PHILIPPINES MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 88. PHILIPPINES MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 89. PHILIPPINES MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SINGAPORE MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SINGAPORE MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SINGAPORE MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 93. SINGAPORE MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. SOUTH KOREA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. SOUTH KOREA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 96. SOUTH KOREA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 97. SOUTH KOREA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. TAIWAN MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. TAIWAN MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 100. TAIWAN MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 101. TAIWAN MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. THAILAND MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. THAILAND MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. THAILAND MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 105. THAILAND MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. VIETNAM MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. VIETNAM MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 108. VIETNAM MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 109. VIETNAM MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 115. DENMARK MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. DENMARK MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 117. DENMARK MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 118. DENMARK MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. EGYPT MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. EGYPT MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 121. EGYPT MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 122. EGYPT MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. FINLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. FINLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 125. FINLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 126. FINLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 129. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 130. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 133. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 134. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. ISRAEL MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. ISRAEL MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. ISRAEL MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 138. ISRAEL MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 141. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 142. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NETHERLANDS MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NETHERLANDS MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 145. NETHERLANDS MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 146. NETHERLANDS MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. NIGERIA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. NIGERIA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 149. NIGERIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 150. NIGERIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. NORWAY MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. NORWAY MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 153. NORWAY MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 154. NORWAY MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. POLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. POLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 157. POLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 158. POLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. QATAR MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. QATAR MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 161. QATAR MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 162. QATAR MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 165. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 166. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SAUDI ARABIA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SAUDI ARABIA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SAUDI ARABIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 170. SAUDI ARABIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SOUTH AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 174. SOUTH AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SPAIN MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SPAIN MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 177. SPAIN MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 178. SPAIN MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. SWEDEN MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. SWEDEN MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 181. SWEDEN MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 182. SWEDEN MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. SWITZERLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. SWITZERLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 185. SWITZERLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 186. SWITZERLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. TURKEY MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. TURKEY MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 189. TURKEY MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 190. TURKEY MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED ARAB EMIRATES MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED ARAB EMIRATES MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED ARAB EMIRATES MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED ARAB EMIRATES MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. UNITED KINGDOM MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 197. UNITED KINGDOM MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 198. UNITED KINGDOM MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. MESENCHYMAL STEM CELLS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 200. MESENCHYMAL STEM CELLS MARKET, FPNV POSITIONING MATRIX, 2023